Newsletter

Subscribe and receive updates on this company

Text STOCKS to 72727 for mobile alerts

We are excited to present Cannabics Pharmaceuticals Inc. (OTC: CNBX).

Full DD Report for CNBX

You must become a subscriber to view this report.


Recent News from (OTC: CNBX)

Cannabics Pharmaceuticals Announces Collaboration With Life Source Partners CEO Muriel Zohar to Optimize Technology Applications and Evaluate New Opportunities
TEL AVIV, Israel and BETHESDA, Maryland , May 2, 2018 /PRNewswire/ -- Cannabics Pharmaceuticals Inc. (CNBX), leader in cannabinoid diagnostic tests for personalized cancer treatment, today announced that CEO of Life Source Partners Ltd., Muriel Zohar, Ph.D, MBA, will be working with...
Source: PR Newswire
Date: May, 02 2018 09:51
5 of Today's Biggest Marijuana Stock Gainers - Tuesday, May 1st
Out of over 200+ marijuana stocks , here are 5 of the biggest marijuana stock winners in trading on Tuesday, May 1st including AXIM Biotechnologies, Inc. (OTC:AXIM) and more... Applied Biosciences Corp. (OTC:APPB) Shares of Applied Biosciences Corp. rose 10.27% on lower than average tr...
Source: Daily Marijuana Observer
Date: May, 01 2018 18:01
Cannabics Pharmaceuticals Announces New Technology Patent
TEL AVIV, Israel and BETHESDA, Maryland , April 18, 2018 /PRNewswire/ -- Cannabics Pharmaceuticals Inc. (OTCQB: CNBX), a leader in cannabinoid diagnostics for the personalized treatment of cancer, today announced the receipt of a Notice of Allowance from The Patent Office ...
Source: PR Newswire
Date: April, 18 2018 08:00
Marijuana Stocks: Winners and Losers March 29, 2018
As marijuana stocks rallied on Thursday several large gains were made in the market. Conversely, volatility still reigns, as cannabis stocks continue their months-long correction. Here are today’s winners and losers in the pot stock market: Cannabics Pharmaceuticals, Inc. (OTC:CNBX) cl...
Source: Pot News
Date: March, 30 2018 04:33
5 of Today's Biggest Marijuana Stock Gainers - Thursday, March 29th
Out of over 200+ marijuana stocks , here are 5 of the biggest marijuana stock winners in trading on Thursday, March 29th including ABcann Global Corp. (TSXV:ABCN) (OTC:ABCCF) and more... ABcann Global Corp. (TSXV:ABCN) (OTC:ABCCF) Shares of ABcann Global Corp. rose 9.89% on lower than ...
Source: Daily Marijuana Observer
Date: March, 29 2018 17:34
Cannabics Pharmaceuticals Receives Positive Results From Preclinical Study on Antitumor Effects of Cannabinoids
TEL AVIV, Israel and BETHESDA, Maryland , March 29, 2018 /PRNewswire/ -- Cannabics Pharmaceuticals Inc. (CNBX), a leader in cannabinoid diagnostic tests for personalized cancer therapy, today announced encouraging results from a preclinical study on the antitumor effects of cannabin...
Source: PR Newswire
Date: March, 29 2018 08:00
5 of Today's Biggest Marijuana Stock Losers - Tuesday, March 27th
Out of over 200+ marijuana stocks, here are just 5 of the biggest marijuana stock losers in trading on Tuesday, March 27th including ABcann Global Corp. (TSXV:ABCN) (OTC:ABCCF) and more... ABcann Global Corp. (TSXV:ABCN) (OTC:ABCCF) Shares of ABcann Global Corp. dropped 8.22% on higher ...
Source: Daily Marijuana Observer
Date: March, 27 2018 16:24
5 of Today's Biggest Marijuana Stock Losers - Wednesday, March 14th
Out of over 200+ marijuana stocks, here are just 5 of the biggest marijuana stock losers in trading on Wednesday, March 14th including Abattis Bioceuticals Corp. (CSE:ATT) (OTC:ATTBF) and more... Abattis Bioceuticals Corp. (CSE:ATT) (OTC:ATTBF) Shares of Abattis Bioceuticals Corp. dropped ...
Source: Daily Marijuana Observer
Date: March, 14 2018 17:32
Cannabis Stock Brief: Pot Stocks Gain As Global Tariff Tensions Ease
The North American Marijuana Index saw slight gains on Thursday, climbing just under two percent following news that President Trump eased up on global tariff tensions. Investor worries lessened as Trump announced exemptions for Canada and Mexico, as well as other for other countries should ...
Source: Pot News
Date: March, 09 2018 04:19
5 of Today's Biggest Marijuana Stock Gainers - Thursday, March 8th
Out of over 200+ marijuana stocks , here are 5 of the biggest marijuana stock winners in trading on Thursday, March 8th including Namaste Technologies Inc. (CSE:N) (OTC:NXTTF) and more... Cannabics Pharmaceuticals, Inc. (OTC:CNBX) Shares of Cannabics Pharmaceuticals, Inc. rose 10.40% on ...
Source: Daily Marijuana Observer
Date: March, 08 2018 17:54

 


About Cannabics Pharmaceuticals Inc. (OTC: CNBX)

Logo for Cannabics Pharmaceuticals Inc. (OTC: CNBX)

Cannabics Pharmaceuticals Inc. CNBX , is dedicated to the development of personalized diagnostic tools to provide supportive data for practitioners and patients regarding cannabinoid based cancer therapy. The Company s R amp D is based in Israel, where it is fully licensed by the Ministry of Health and involves both scientific and current medical clinical studies which are registered with the US NIH. Cannabics is now creating tailored therapies for cancer patients, utilizing advanced Liquid Biopsy and HTS technology along with personalized bioinformatics tools. Cannabics research is devoted to the discovery of cannabinoid compounds targeted to specific cancers based on the confluence of cutting edge technologies and personalized bioinformatic markers.

 

 

 

Current Management

  • Eyal Barad / CEO
    • Eyal Barad , is a cofounder of Cannabics Inc., founded in , and is a core member of Cannabics Inc. s management team and brings years of executive managerial experience in successful technology and startup ventures. Mr. Barad received his BA in Economics amp International Relations from the Hebrew University in Jerusalem in , and an MBA with Honors from Haifa University in
  • Uri BenOr / CFO
    • Mr. BenOr has over years of broad experience in corporate finance, accounting, M amp A transactions and IPOs. He specializes in life science public companies listed for trade at the TASE and serves as the CFO of many of them. Mr. BenOr has a BA degree in Business from the College of Administration, a MBA degree from the Bar Ilan University and he is a Certified Public Accountant.
  • Eyal Ballan / CTO
  • Eyal Ballan /

Current Share Structure

  • Market Cap: $162,655,657 - 03/09/2018
  • Authorized: 900,000,000 - 02/28/2018
  • Issue and Outstanding: 120,485,672 - 02/28/2018
  • Float: 21,943,046 - 06/01/2017

 


Recent Filings from (OTC: CNBX)

Report of unscheduled material events or corporate changes.
Filing Type: 8-KFiling Source: edgar
Filing Date: May, 02 2018
Quarterly report with a continuing view of a company's financial position
Filing Type: 10-QFiling Source: edgar
Filing Date: April, 05 2018
Report of unscheduled material events or corporate changes.
Filing Type: 8-KFiling Source: edgar
Filing Date: February, 14 2018
Report of unscheduled material events or corporate changes.
Filing Type: 8-KFiling Source: edgar
Filing Date: January, 30 2018
Quarterly report with a continuing view of a company's financial position
Filing Type: 10-QFiling Source: edgar
Filing Date: January, 16 2018
OTCQB Certification - OTCQB Certification
Filing Type: OTCQB Certification - OTCQB CertificationFiling Source: OTC Markets
Filing Date: January, 10 2018
Report of unscheduled material events or corporate changes.
Filing Type: 8-KFiling Source: edgar
Filing Date: December, 19 2017
Annual report with a comprehensive overview of the company
Filing Type: 10-KFiling Source: edgar
Filing Date: December, 08 2017
Notification that form 10-K will be submitted late
Filing Type: NT 10-KFiling Source: edgar
Filing Date: November, 29 2017
Report of unscheduled material events or corporate changes.
Filing Type: 8-KFiling Source: edgar
Filing Date: November, 13 2017

 

 


Daily Technical Chart for (OTC: CNBX)

Daily Technical Chart for (OTC: CNBX)


Stay tuned for daily updates and more on (OTC: CNBX)

It most certainly could but even more important is the recent overwhelming interest in the company. Check out Investors Hub and search on Twitter

More to come on (OTC: CNBX)

Do your DD and if you choose, be ready to go!


 

The Research: All source information contained in this email is from the public sources mentioned below.

 

 
 

Thank you

OTC Report
@OTCReporter

 

 


Disclaimer: OTC Report publishes reports providing information on selected companies. OTC Report is not a registered investment advisor or broker-dealer. This report is provided as an information service only, and the statements and opinions in this report should not be construed as an offer or solicitation to buy or sell any security. OTC Report accepts no liability for any loss arising from an investors reliance on or use of this report. An investment in CNBX is considered to be highly speculative and should not be considered unless a person can afford a complete loss of investment. OTC Report has received up to $100,000 worth of crypto currency from a non-affiliated third party for the publication and circulation of this report. OTC Report does not own any shares of CNBX and does not buy, sell, or trade any shares of CNBX. This report contains forward-looking statements, which involve risks, and uncertainties that may cause actual results to differ materially from those set forth in the forward-looking statements. Copyright 2018 by OTC Report. All rights reserved. Our Full Disclaimer: http://otc.report/disclaimer/